trial · primary record
HS-20093 for injection
Advanced Gastric and Gastroesophageal Junction Adenocarcinoma
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 40 |
| Primary completion | 2028-03-31 |
| Primary endpoint | Objective response rate (ORR) determined by investigators according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1. |
| Registry ID | NCT07462923 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:43:15.672Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07462923
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.